Track topics on Twitter Track topics that are important to you
NEW YORK, June 3, 2015 (GLOBE NEWSWIRE) -- Houlihan Lokey, the international investment bank, today announced that Jon Pritti has joined the firm's Healthcare Group as a Director. Mr. Pritti is based in New York, reporting to Mark Francis, Managing Director and Head of the Healthcare Group. Mr. Pritti will primarily focus on continuing to build the Healthcare Group's revenue cycle management services, outsourced services, consulting, and distribution franchises.
Mr. Pritti joins Houlihan Lokey from Cain Brothers, where he was a Managing Director providing M &A and capital raising investment banking services to healthcare services clients. Prior to Cain Brothers, Mr. Pritti was a member of the Healthcare Investment Banking Group at Goldman, Sachs & Co. Over the course of his career, he has advised on transactions with an aggregate enterprise value in excess of $15 billion.
"Jon's significant experience and depth of relationships in the sector will enhance the group's capability to provide the finest advice to our clients on a full range of M &A and capital markets strategies," said Mr. Francis. "We're excited to have him join as we continue to expand our leading healthcare investment banking group," he added. In 2014, Houlihan Lokey's Healthcare Group advised on 24 healthcare M &A transactions, earning the No. 1 ranking for U.S. Healthcare transactions under $1 billion, according to Thomson Reuters.
Mr. Pritti holds a B.B.A. in Accounting from Emory University and an MBA in Finance from Columbia Business School.
Houlihan Lokey is an international investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of our commitment to client success across our advisory services. Houlihan Lokey is ranked as the No. 1 M &A advisor for U.S. transactions under $5 billion, the No. 1 global restructuring advisor, and the No. 1 M &A fairness opinion advisor for U.S. transactions over the past 10 years, according to Thomson Reuters. For more information, please visit www.HL.com.
For press inquiries, contact John Gallagher at 212.497.4220.
CONTACT: John Gallagher 212.497.4220 (W) 917.331.1580 (M)NEXT ARTICLE
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...